Matches in Wikidata for { <http://www.wikidata.org/entity/Q28577794> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q28577794 description "2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած" @default.
- Q28577794 description "2006 թվականի փետրվարին հրատարակված գիտական հոդված" @default.
- Q28577794 description "article scientifique publié en 2006" @default.
- Q28577794 description "artículu científicu espublizáu en 2006" @default.
- Q28577794 description "im Februar 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q28577794 description "scientific journal article" @default.
- Q28577794 description "vedecký článok (publikovaný 2006/02/01)" @default.
- Q28577794 description "vědecký článek publikovaný v roce 2006" @default.
- Q28577794 description "wetenschappelijk artikel (gepubliceerd op 2006/02/01)" @default.
- Q28577794 description "наукова стаття, опублікована в лютому 2006" @default.
- Q28577794 description "مقالة علمية (نشرت في فبراير 2006)" @default.
- Q28577794 name "Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes" @default.
- Q28577794 name "Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes" @default.
- Q28577794 name "Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes" @default.
- Q28577794 type Item @default.
- Q28577794 label "Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes" @default.
- Q28577794 label "Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes" @default.
- Q28577794 label "Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes" @default.
- Q28577794 prefLabel "Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes" @default.
- Q28577794 prefLabel "Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes" @default.
- Q28577794 prefLabel "Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes" @default.
- Q28577794 P1433 Q28577794-36AB2981-682C-4E94-BB47-C0801976141D @default.
- Q28577794 P1476 Q28577794-757C4F73-7D03-4DDF-9900-CD20A1B22D5D @default.
- Q28577794 P2093 Q28577794-09B22D76-AA4E-4603-82EF-625819696562 @default.
- Q28577794 P2093 Q28577794-2720A3BD-B253-4DA6-989C-00C0C6D45D61 @default.
- Q28577794 P2093 Q28577794-479D9D27-AAA5-4AF2-A71E-F5464A52DB05 @default.
- Q28577794 P2093 Q28577794-68332400-E30B-450C-80DC-AE3FB2E7BF66 @default.
- Q28577794 P2093 Q28577794-75CB248B-BEA2-4D69-A42F-A8E96A36F41D @default.
- Q28577794 P2093 Q28577794-8B16E7D6-B1C4-4A2A-9CDC-CACE02A09D76 @default.
- Q28577794 P2093 Q28577794-8FA5A1E2-A319-4960-B8BE-0F36C2BD2C12 @default.
- Q28577794 P2093 Q28577794-D0EB8042-55A3-47F3-86CF-DA710FB738CF @default.
- Q28577794 P2093 Q28577794-EECBAF4B-C785-4350-8C34-BA1FD7022D6E @default.
- Q28577794 P304 Q28577794-1FEC4267-9559-467C-9800-8DE3CCBB267D @default.
- Q28577794 P31 Q28577794-B9552C21-7FC7-4122-AE90-54948918763D @default.
- Q28577794 P3181 Q28577794-6936BCFE-BADA-49E5-98BD-31ABFC34F7C6 @default.
- Q28577794 P356 Q28577794-D3E07F2E-1113-4913-9CA6-6E39FFC31A01 @default.
- Q28577794 P433 Q28577794-905EC653-571A-404F-9B0D-19AB0C24AECF @default.
- Q28577794 P478 Q28577794-1FBA0A42-9704-4FE4-86A1-E86C619AED66 @default.
- Q28577794 P577 Q28577794-F242116B-A30B-4F8A-807C-C9F5DA57100A @default.
- Q28577794 P698 Q28577794-154454D4-BBE9-4F12-890A-05968715AF6E @default.
- Q28577794 P921 Q28577794-06EC8F6F-32DB-493F-81AF-5BA9093BA848 @default.
- Q28577794 P921 Q28577794-934DF22A-8EFD-4003-859B-7BDEB467E9DF @default.
- Q28577794 P3181 4022877 @default.
- Q28577794 P356 J.YJMCC.2005.11.007 @default.
- Q28577794 P698 16427075 @default.
- Q28577794 P1433 Q2061932 @default.
- Q28577794 P1476 "Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes" @default.
- Q28577794 P2093 "Hisao Hirota" @default.
- Q28577794 P2093 "Ichiro Kawase" @default.
- Q28577794 P2093 "Kazuo Terai" @default.
- Q28577794 P2093 "Masahiro Izumi" @default.
- Q28577794 P2093 "Masatsugu Hori" @default.
- Q28577794 P2093 "Mitsuru Masaki" @default.
- Q28577794 P2093 "Shoko Sugiyama" @default.
- Q28577794 P2093 "Tadashi Kuroda" @default.
- Q28577794 P2093 "Yoshimune Hiramoto" @default.
- Q28577794 P304 "224–233" @default.
- Q28577794 P31 Q13442814 @default.
- Q28577794 P3181 "4022877" @default.
- Q28577794 P356 "10.1016/J.YJMCC.2005.11.007" @default.
- Q28577794 P433 "2" @default.
- Q28577794 P478 "40" @default.
- Q28577794 P577 "2006-02-01T00:00:00Z" @default.
- Q28577794 P698 "16427075" @default.
- Q28577794 P921 Q29496 @default.
- Q28577794 P921 Q815547 @default.